Evidence map›Paper›PMID 35451369›Full record

SynthesisReproduction (Cambridge, England)2022

A systematic review and standardized clinical validity assessment of genes involved in female reproductive failure.

Ludmila Volozonoka, Anna Miskova, Liene Kornejeva, Inga Kempa, Veronika Bargatina, Linda Gailite

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Reproduction (Cambridge, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 21 citations in OpenAlex.

  1. Pathogenicity assessment of genetic variants in reproductive disorders.Journal of assisted reproduction and genetics · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Genetics of Female and Male Infertility.Deutsches Arzteblatt international · 2025
    Review
  9. Article
  10. Review
  11. Genetics of female and male infertility.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2024
    Article
  12. Article
  13. Genomic aspects in reproductive medicine.Clinical and experimental reproductive medicine · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. The Role ofJournal of clinical medicine · 2023
    Article
  18. Article
  19. UterusFrontiers in neurology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ludmila VolozonokaScientific Laboratory of Molecular Genetics, Riga Stradins University, Riga, Latvia.ORCID 0000-0003-0413-1481
Anna MiskovaDepartment of Obstetrics and Gynaecology, Riga Stradins University, Riga, Latvia.
Liene KornejevaRiga Maternity Hospital, Riga, LV-1013, Latvia.
Inga KempaScientific Laboratory of Molecular Genetics, Riga Stradins University, Riga, Latvia.
Veronika BargatinaE. Gulbja Laboratory, Riga, LV-1006, Latvia.
Linda GailiteScientific Laboratory of Molecular Genetics, Riga Stradins University, Riga, Latvia.
Latvia Business College · LVRiga East University Hospital · LVRiga Stradiņš University · LV

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic testing is becoming increasingly required at almost every stage of failed female reproduction/infertility. Nonetheless, clinical evidence for the majority of identified gene-disease relationships is ill-defined, thus leading to difficult gene variant interpretation and poor translation of existing knowledge into clinics. We aimed to identify the genes that have ever been implicated in monogenic female reproductive failure in humans and to classify the identified gene-disease relationship pairs using a standardized clinical validity assessment. A PubMed search following PRISMA guidelines was conducted on 20 September 2021 aiming to identify studies pertaining to genetic causes of phenotypes of female reproductive failure. The clinical validity of identified gene-disease pairs was assessed using standardized criteria, counting whether sufficient genetic and experimental evidence has been accumulated to consider a single gene 'characterized' for a single Mendelian disease. In total, 1256 articles were selected for the data extraction; 183 unique gene-disease pairs were classified spanning the following phenotypes: hypogonadotropic hypogonadism, ovarian dysgenesis, premature ovarian failure/insufficiency, ovarian hyperstimulation syndrome, empty follicle syndrome, oocyte maturation defect, fertilization failure, early embryonic arrest, recurrent hydatidiform mole, adrenal disfunction and Mullerian aplasia. Twenty-four gene-disease pairs showed definitive evidence, 36 - strong, 19 - moderate, 81 - limited and 23 - showed no evidence. Here, we provide comprehensive, systematic and timely information on the genetic causes of female infertility. Our classification of genetic causes of female reproductive failure will facilitate the composition of up-to-date guidelines on genetic testing in female reproduction, the development of diagnostic gene panels and the advancement of reproductive decision-making.

Indexed as

Infertility, FemaleOvarian Hyperstimulation SyndromeFemaleGenetic TestingHumansNeoplasm Recurrence, LocalOocytesPregnancy

Identifiers

PMID35451369
PMCPMC9066658
OpenAlexW4224229657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.